The departures followed a disagreement between the board and its majority shareholder over future governance.

Novo Nordisk directors and the firm's controlling shareholder failed to reach an agreement on the future composition of the board.

La Fundación provoca una renovación casi total del consejo. El grupo danés sufre nuevas caídas en Bolsa y ya se deja un 45% desde enero

The departures followed a disagreement between the board and its majority shareholder over future governance.